<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1393" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1393/" /><meta name="ncbi_pagename" content="X-Linked Otopalatodigital Spectrum Disorders - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>X-Linked Otopalatodigital Spectrum Disorders - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="X-Linked Otopalatodigital Spectrum Disorders" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2019/10/03" /><meta name="citation_author" content="Stephen Robertson" /><meta name="citation_pmid" content="20301567" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1393/" /><meta name="citation_keywords" content="Otopalatodigital Spectrum Disorders (OPDSD)" /><meta name="citation_keywords" content="Otopalatodigital Spectrum Disorders (OPDSD)" /><meta name="citation_keywords" content="Otopalatodigital Syndrome Type 1 (OPD1)" /><meta name="citation_keywords" content="Frontometaphyseal Dysplasia Type 1 (FMD1)" /><meta name="citation_keywords" content="Melnick-Needles Syndrome (MNS)" /><meta name="citation_keywords" content="Otopalatodigital Syndrome Type 2 (OPD2)" /><meta name="citation_keywords" content="Terminal Osseous Dysplasia with Pigmentary Skin Defects (TODPD)" /><meta name="citation_keywords" content="Filamin-A" /><meta name="citation_keywords" content="FLNA" /><meta name="citation_keywords" content="X-Linked Otopalatodigital Spectrum Disorders" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="X-Linked Otopalatodigital Spectrum Disorders" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Stephen Robertson" /><meta name="DC.Date" content="2019/10/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1393/" /><meta name="description" content="The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following:" /><meta name="og:title" content="X-Linked Otopalatodigital Spectrum Disorders" /><meta name="og:type" content="book" /><meta name="og:description" content="The X-linked otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1393/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/opd/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1393/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8A1166E0404FB10000000006A2024B.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1393_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1393_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/opitz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/epp-xl/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1393_"><span class="title" itemprop="name">X-Linked Otopalatodigital Spectrum Disorders</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: Otopalatodigital Spectrum Disorders (OPDSD)</div><p class="contrib-group"><span itemprop="author">Stephen Robertson</span>, FRACP, DPhil.</p><a data-jig="ncbitoggler" href="#__NBK1393_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1393_ai__"><div class="contrib half_rhythm"><span itemprop="author">Stephen Robertson</span>, FRACP, DPhil<div class="affiliation small">Department of Women's and Children's Health<br />Dunedin School of Medicine<br />University of Otago<br />Dunedin, New Zealand<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="zn.ca.ogato@nostrebor.nehpets" class="oemail">zn.ca.ogato@nostrebor.nehpets</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 30, 2005</span>; Last Update: <span itemprop="dateModified">October 3, 2019</span>.</p><p><em>Estimated reading time: 27 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="opd.Summary" itemprop="description"><h2 id="_opd_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorders, characterized primarily by skeletal dysplasia, include the following:</p><ul><li class="half_rhythm"><div>Otopalatodigital syndrome type 1 (OPD1)</div></li><li class="half_rhythm"><div>Otopalatodigital syndrome type 2 (OPD2)</div></li><li class="half_rhythm"><div>Frontometaphyseal dysplasia type 1 (FMD1)</div></li><li class="half_rhythm"><div>Melnick-Needles syndrome (MNS)</div></li><li class="half_rhythm"><div>Terminal osseous dysplasia with pigmentary skin defects (TODPD)</div></li></ul><p>In OPD1, most manifestations are present at birth; females can present with severity similar to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males, although some have only mild manifestations. In OPD2, females are less severely affected than related affected males. Most males with OPD2 die during the first year of life, usually from thoracic hypoplasia resulting in pulmonary insufficiency. Males who live beyond the first year of life are usually developmentally delayed and require respiratory support and assistance with feeding. In FMD1, females are less severely affected than related affected males. Males do not experience a progressive skeletal dysplasia but may have joint contractures and hand and foot malformations. Progressive scoliosis is observed in both affected males and females. In MNS, wide phenotypic variability is observed; some individuals are diagnosed in adulthood, while others require respiratory support and have reduced longevity. MNS in males results in perinatal lethality in all recorded cases. TODPD, seen only in females, is characterized by a skeletal dysplasia that is most prominent in the digits, pigmentary defects of the skin, and recurrent digital fibromata.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The diagnosis of an X-OPD spectrum disorder is established in a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical and radiographic features and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis if clinical features, radiographic features, and/or family history are inconclusive.</p><p>The diagnosis of an X-OPD spectrum disorder is usually established in a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with characteristic clinical and radiographic features and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis if clinical features, radiographic features, and/or family history are inconclusive.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Surgical treatment may be required for hand and foot malformations. Monitoring and surgical intervention as needed for scoliosis; physiotherapy for contractures; cosmetic surgery may correct the fronto-orbital deformity; continuous positive airway pressure (CPAP) and mandibular distraction can improve airway complications related to micrognathia; hearing aids for deafness; evaluation with anesthesiology if intubation and ventilation are required due to laryngeal stenosis.</p><p><i>Surveillance:</i> Annual clinical evaluation for orthopedic complications including contractures and scoliosis; monitor head size and shape with each clinical evaluation in infancy for craniosynostosis; annual clinical evaluation for apnea with somnography studies as indicated; annual audiology evaluation.</p><p><i>Evaluation of relatives at risk:</i> Consider <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the family-specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in at-risk relatives.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The X-OPD spectrum disorders are by definition inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. If a parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with OPD1, OPD2, or FMD1 has the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting the variant in each pregnancy is 50%.</p><ul><li class="half_rhythm"><div>When the mother has an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, males who inherit the variant will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>; females who inherit the variant have a range of phenotypic expression. If the mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with TODPD or MNS has the <i>FLNA</i> pathogenic variant, the chance of transmitting the variant in each pregnancy is 50%. Males who inherit the variant will be affected and usually exhibit embryonic lethality or die perinatally (MNS); females who inherit the variant have a range of phenotypic expression.</div></li><li class="half_rhythm"><div>Males with OPD2 do not reproduce; males with OPD1 or FMD1 transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters and none of their sons.</div></li></ul><p>Prenatal diagnosis for pregnancies at increased risk is possible if the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family is known.</p></div></div><div id="opd.GeneReview_Scope"><h2 id="_opd_GeneReview_Scope_"><i>GeneReview</i> Scope</h2><div id="opd.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.Tc_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.Tc_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">X-Linked Otopalatodigital Spectrum Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th></tr></thead><tbody><tr><td headers="hd_h_opd.Tc_1_1_1_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Otopalatodigital syndrome type 1 (OPD1)</div></li><li class="half_rhythm"><div>Otopalatodigital syndrome type 2 (OPD2)</div></li><li class="half_rhythm"><div>Frontometaphyseal dysplasia type 1 (FMD1)</div></li><li class="half_rhythm"><div>Melnick-Needles syndrome (MNS)</div></li><li class="half_rhythm"><div>Terminal osseous dysplasia with pigmentary skin defects (TODPD)</div></li></ul>
</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">For synonyms and outdated names see <a href="#opd.Nomenclature">Nomenclature</a>.</p></div></dd><dt>1. </dt><dd><div id="opd.TF.c.1"><p class="no_margin">For other genetic causes of these phenotypes see <a href="#opd.Differential_Diagnosis">Differential Diagnosis</a>.</p></div></dd></dl></div></div></div></div><div id="opd.Diagnosis"><h2 id="_opd_Diagnosis_">Diagnosis</h2><p>The <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorders, a heterogeneous group of disorders characterized primarily by a skeletal dysplasia of variable severity, include the following:</p><ul><li class="half_rhythm"><div>Otopalatodigital syndrome type 1 (OPD1)</div></li><li class="half_rhythm"><div>Otopalatodigital syndrome type 2 (OPD2)</div></li><li class="half_rhythm"><div>Frontometaphyseal dysplasia type 1 (FMD1)</div></li><li class="half_rhythm"><div>Melnick-Needles syndrome (MNS)</div></li><li class="half_rhythm"><div>Terminal osseous dysplasia with pigmentary skin defects (TODPD)</div></li></ul><div id="opd.Suggestive_Findings"><h3>Suggestive Findings</h3><p>X-OPD spectrum disorders <b>should be suspected</b> in an individual with the following clinical (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum" rid-ob="figobopdTxlinkedotopalatodigitalspectrum">Table 1</a>) and radiographic (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum1" rid-ob="figobopdTxlinkedotopalatodigitalspectrum1">Table 2</a>) features.</p><div id="opd.T.xlinked_otopalatodigital_spectrum" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>X-Linked Otopalatodigital Spectrum Disorders: Clinical Features</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.xlinked_otopalatodigital_spectrum_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Craniofacial Features</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal Features</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Other</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD1</b><br /><b>(male</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Cleft palate &#x00026; characteristic facies: prominent supraorbital ridges, downslanted palpebral fissures, hypertelorism, broad nasal bridge &#x00026; nasal tip, hypodontia, oligodontia</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Digits: short proximally placed thumbs, hypoplastic distal phalanges, great toe hypoplasia, long 2nd toe, prominent sandal gap; limited joint mobility; limbs w/mild bowing</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conductive &#x00026; sensorineural hearing loss; normal intelligence</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Heterozygous females&#x000a0;<sup>1</sup>:</b> variable features; some females as <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> as male relatives.</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD2</b><br /><b>(male</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Pierre Robin sequence; characteristic facies (more severe than OPD1)</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Digits: hypoplastic thumbs &#x00026; great toes, absent halluces, camptodactyly; thoracic hypoplasia; delayed closure of fontanelles; bowed limbs; short stature</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conductive &#x00026; SNHL; cardiac: septal defects, obstructive lesions to the right ventricular outflow tract; omphalocele; GU: ureteric obstruction w/hydronephrosis, hypospadias; CNS: hydrocephalus, cerebellar hypoplasia; DD; death in neonatal period</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Heterozygous females&#x000a0;<sup>1</sup>:</b> often subclinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; characteristic facies (prominent supraorbital ridges, wide nasal bridge &#x00026; broad nasal tip) are most common findings. Occasionally conductive HL, cleft palate, skeletal &#x00026; digital anomalies.</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>FMD1</b><br /><b>(male</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Characteristic facies (more severe than OPD2)</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Digits: distal phalangeal hypoplasia, progressive contractures of the hands; limited joint mobility (wrists, elbows, knees, ankles); scoliosis; bowed limbs</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conductive &#x00026; SNHL; underdevelopment of musculature (shoulder girdle, intrinsic muscles of the hands); subglottic stenosis w/<a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> stridor; GU: ureteric &#x00026; urethral stenosis, hydronephrosis; normal intelligence</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Heterozygous females:</b> characteristic facies similar to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>MNS</b><br /><b>(female</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Prominent lateral margins of the supraorbital ridges, proptosis, full cheeks, micrognathia, oligohypodontia, facial asymmetry</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Digits: long w/mild distal phalangeal hypoplasia; thoracic hypoplasia; bowed limbs; joint subluxation; short stature</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Conductive &#x00026; SNHL; ureteric obstruction w/hydronephrosis; coloboma; normal intelligence</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Hemizygous males:</b> <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> ranges from lethal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to severe OPD2 to mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>TODPD</b><br /><b>(female</b><br /><b><a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Widely spaced eyes, oral frenulae, hyperpigmented lesions over the temporal region, alopecia</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">Digits: fibromata in infancy, camptodactyly; bowed limbs; short stature</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cardiac: septal defects; normal intelligence</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_4" colspan="1" scope="col" rowspan="1" style="text-align:left;vertical-align:middle;"><b>Hemizygous males:</b> <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> has not been described in males.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">DD = developmental delay; FMD1 = frontometaphyseal dysplasia type 1; GU = genitourinary; MNS = Melnick-Needles syndrome; OPD1 = otopalatodigital syndrome type 1; OPD2 = otopalatodigital syndrome type 2; SNHL = sensorineural hearing loss; TODPD = terminal osseous dysplasia with pigmentary skin defects</p></div></dd><dt>1. </dt><dd><div id="opd.TF.1.1"><p class="no_margin">OPD1 and OPD2 cannot be clinically differentiated in a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female in a family with no affected males.</p></div></dd></dl></div></div></div><div id="opd.T.xlinked_otopalatodigital_spectrum_1" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>X-Linked Otopalatodigital Spectrum Disorders: Radiographic Features</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.xlinked_otopalatodigital_spectrum_1_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skull</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Spine</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thorax</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Long Bones</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hands / Feet</th><th id="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Pelvis</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD1</b><br /><b>(male <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sclerosis of skull base; thickened calvarium; underdeveloped frontal sinuses; mastoids under-pneumatized</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Failure of fusion of posterior vertebral arches (especially cervical)</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild bowing; dislocation of radial heads</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thumb w/short, broad metacarpal; distal phalangeal hypoplasia; accessory proximal ossification center of 2nd metacarpal; accessory carpal bones; fusion of carpal &#x00026; tarsal bones</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Contracted; no iliac flaring</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD2</b><br /><b>(male <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as OPD1; large fontanelles</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as OPD1; segmentation anomalies</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplastic; thin ribs</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bowed; splayed metaphyses; absent fibulae</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Broad, poorly modeled phalanges, metacarpals &#x00026; metatarsals; &#x000b1; duplicated terminal phalanges</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as OPD1</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>FMD1</b><br /><b>(male <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as OPD1; occasionally, craniosynostosis</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Fusion of C2-3-4; deficiency of posterior vertebral arches</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x000b1; coat-hanger shape ribs</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mild bowing; undertubulation</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carpal &#x00026; tarsal fusions; later erosion of carpal bones; elongation, poor modeling of phalanges, metacarpals &#x00026; metatarsals; distal phalangeal hypoplasia (thumbs &#x00026; great toes)</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>MNS</b><br /><b>(female <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Same as OPD1</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x02191; vertebral body height, especially lumbar; scoliosis</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplasia; ribs irregular; wavy clavicle w/expansion of proximal end</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bowed, sometimes ribbon-like; cortical irregularity</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Elongation &#x00026; undermodeling of phalanges, metacarpals &#x00026; metatarsals</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Supra-acetabular constriction; iliac flaring</td></tr><tr><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>TODPD</b><br /><b>(female <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>)</b></td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Normal</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Scoliosis</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">No abnormalities consistently described</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_5" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Irregular ossification; cystic lesions near epiphyses; bowed; radial head dislocation</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_6" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hypoplasia, shortening, irregular ossification &#x00026;/or fusions of carpals &#x00026; metacarpals; irregular cortices</td><td headers="hd_h_opd.T.xlinked_otopalatodigital_spectrum_1_1_1_1_7" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Narrow ilia; coxa vara</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FMD1 = frontometaphyseal dysplasia type 1; MNS = Melnick-Needles syndrome; OPD1 = otopalatodigital syndrome type 1; OPD2 = otopalatodigital syndrome type 2; TODPD = terminal osseous dysplasia with pigmentary skin defects</p></div></dd></dl></div></div></div></div><div id="opd.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p><b>Male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of an X-OPD spectrum disorder <b>is established</b> in a male proband with characteristic clinical (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum" rid-ob="figobopdTxlinkedotopalatodigitalspectrum">Table 1</a>) and radiographic (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum1" rid-ob="figobopdTxlinkedotopalatodigitalspectrum1">Table 2</a>) features and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis if clinical features, radiographic features, and/or family history are inconclusive (see <a class="figpopup" href="/books/NBK1393/table/opd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figopdTmoleculargenetictestingusedin" rid-ob="figobopdTmoleculargenetictestingusedin">Table 3</a>).</p><p><b>Female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The diagnosis of an X-OPD spectrum disorder <b>is usually established</b> in a female proband with characteristic clinical (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum" rid-ob="figobopdTxlinkedotopalatodigitalspectrum">Table 1</a>) and radiographic (<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum1" rid-ob="figobopdTxlinkedotopalatodigitalspectrum1">Table 2</a>) features and a family history consistent with <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> inheritance. Identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> can confirm the diagnosis if clinical features, radiographic features, and/or family history are inconclusive (see <a class="figpopup" href="/books/NBK1393/table/opd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object" rid-figpopup="figopdTmoleculargenetictestingusedin" rid-ob="figobopdTmoleculargenetictestingusedin">Table 3</a>).</p><p><b>Molecular genetic testing</b> approaches can include a combination of <b><a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted testing</b> (single-gene testing, <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a>) and <b>comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (<a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a>, <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a>) depending on the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Gene-targeted testing requires that the clinician determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>(s) are likely involved, whereas <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing does not. Because the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of X-OPD spectrum disorders is broad, individuals with the distinctive findings described in <a href="#opd.Suggestive_Findings">Suggestive Findings</a> are likely to be diagnosed using gene-targeted testing (see <a href="#opd.Option_1">Option 1</a>), whereas those in whom the diagnosis of an X-OPD spectrum disorder has not been considered are more likely to be diagnosed using genomic testing (see <a href="#opd.Option_2">Option 2</a>).</p><div id="opd.Option_1"><h4>Option 1</h4><p>When the phenotypic and laboratory findings suggest the diagnosis of an X-OPD spectrum disorder, <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b> or use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Perform <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>FLNA</i> to detect small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</div><div class="half_rhythm">Note: Whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions cause periventricular nodular heterotopia in females and are likely to be embryonic lethal in males. Partial-gene deletions or duplications have not been associated with X-OPD spectrum disorders. Whole-gene duplications (in association with neighboring genes) have been associated with intellectual disability and seizures (see <a href="#opd.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>).</div><div class="half_rhythm">Targeted analysis for variant <a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">c.5217G&#x0003e;A</a> can be performed first in individuals with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> suggestive of TODPD; however, this test is not exclusionary for TODPD.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>FLNA</i> and other genes of interest (see <a href="#opd.Differential_Diagnosis">Differential Diagnosis</a>) is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li></ul></div><div id="opd.Option_2"><h4>Option 2</h4><p>When the diagnosis of an X-OPD spectrum disorder is not considered because an individual has atypical phenotypic features, <b>comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (which does not require the clinician to determine which <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>[s] are likely involved) is the best option. <b>Exome sequencing</b> is the most commonly used genomic testing method; <b><a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a></b> is also possible.</p><p>For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</p><div id="opd.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in X-Linked Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Phenotype</th><th id="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by Method</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="6" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNA</i></td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="4" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OPD1</td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">94% (n=15)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">OPD2</td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (n=19)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">FMD1</td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">71% (n=47)&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">MNS</td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (n=27)&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for <a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">c.5217G&#x0003e;A</a></td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">TODPD</td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100% (n=6)&#x000a0;<sup>6</sup></td></tr><tr><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>7</sup></td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:top;"></td><td headers="hd_h_opd.T.molecular_genetic_testing_used_in_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">None&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FMD1 = frontometaphyseal dysplasia type 1; MNS = Melnick-Needles syndrome; OPD1 = otopalatodigital syndrome type 1; OPD2 = otopalatodigital syndrome type 2; TODPD = terminal osseous dysplasia with pigmentary skin defects</p></div></dd><dt>1. </dt><dd><div id="opd.TF.3.1"><p class="no_margin">See <a href="/books/NBK1393/#opd.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="opd.TF.3.2"><p class="no_margin">See <a href="#opd.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="opd.TF.3.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="opd.TF.3.4"><p class="no_margin"><a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al [2006b]</a></p></div></dd><dt>5. </dt><dd><div id="opd.TF.3.5"><p class="no_margin"><a class="bk_pop" href="#opd.REF.robertson.2006a.1726">Robertson et al [2006a]</a>, <a class="bk_pop" href="#opd.REF.wade.2016.392">Wade et al [2016]</a></p></div></dd><dt>6. </dt><dd><div id="opd.TF.3.6"><p class="no_margin">All reported individuals with TODPD have been <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the synonymous change <a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">c.5217G&#x0003e;A</a>, which induces a <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> abnormality that results in a loss of 48 bases from the mature transcript and predicts the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 16 amino acids from the resultant FLNA protein (<a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">p.Val1724_Thr1739del</a>) [<a class="bk_pop" href="#opd.REF.sun.2010.146">Sun et al 2010</a>]. This <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> appears to define this disorder.</p></div></dd><dt>7. </dt><dd><div id="opd.TF.3.7"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>8. </dt><dd><div id="opd.TF.3.8"><p class="no_margin">Large deletions and duplications have been associated with allelic conditions such as myxomatous cardiac valvular dystrophy (see <a href="#opd.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>), periventricular nodular heterotopia, and intellectual disability. Partial- and whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions do not cause an X-OPD spectrum disorder <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div></dd></dl></div></div></div></div></div></div><div id="opd.Clinical_Characteristics"><h2 id="_opd_Clinical_Characteristics_">Clinical Characteristics</h2><div id="opd.Clinical_Description"><h3>Clinical Description</h3><p>To date, more than 150 individuals with an X-OPD syndrome spectrum disorder have been identified with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>FLNA</i> [<a class="bk_pop" href="#opd.REF.robertson.2003.487">Robertson et al 2003</a>, <a class="bk_pop" href="#opd.REF.robertson.2006a.1726">Robertson et al 2006a</a>, <a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al 2006b</a>]. The following description of the phenotypic features associated with this condition is based on these reports.</p><div id="opd.T.features_of_xlinked_otopalatodigit" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p>Features of X-Linked Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.features_of_xlinked_otopalatodigit/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.features_of_xlinked_otopalatodigit_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Features</th><th id="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">% of Persons with Feature</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD1 in males</b></td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Digital anomalies</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Deafness</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Mild limb bowing</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cleft Palate</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">75%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>OPD2 in males</b></td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Thoracic hypoplasia</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Cleft palate</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">80%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>FMD1 in males</b></td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Supraorbital hyperostosis</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Urinary Tract obstruction</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>MNS in females</b></td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Micrognathia</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Limb bowing</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Short stature</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Thoracic hypoplasia</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>TODPD in females</b></td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Digital fibromata</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Erosive changes on radiographs</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Limb bowing</td><td headers="hd_h_opd.T.features_of_xlinked_otopalatodigit_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FMD1 = frontometaphyseal dysplasia type 1; MNS = Melnick-Needles syndrome; OPD1 = otopalatodigital syndrome type 1; OPD2 = otopalatodigital syndrome type 2; TODPD = terminal osseous dysplasia with pigmentary skin defects</p></div></dd></dl></div></div></div><p>Little is known about the natural history of the <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorders. All manifestations can begin in childhood in both sexes.</p><p>In males, the spectrum of severity ranges from mild manifestations in otopalatodigital syndrome type 1 (OPD1) to a more severe presentation in frontometaphyseal dysplasia type 1 (FMD1) and otopalatodigital syndrome type 2 (OPD2). Prenatal lethality is the only clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> described in males with Melnick-Needles syndrome (MNS) [<a class="bk_pop" href="#opd.REF.spencer.2018.980">Spencer et al 2018</a>].</p><p>Females exhibit <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>. In OPD1, females can present with similar severity to <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males. In contrast, some females have only the mildest of manifestations [<a class="bk_pop" href="#opd.REF.gorlin.1973.218">Gorlin et al 1973</a>]. In OPD2 and FMD1, females are less severely affected than related affected males [<a class="bk_pop" href="#opd.REF.robertson.1997.341">Robertson et al 1997</a>, <a class="bk_pop" href="#opd.REF.moutton.2016.693">Moutton et al 2016</a>].</p><div id="opd.OPD1"><h4>OPD1</h4><p>Most manifestations are evident at birth. Nothing reported in the literature suggests any late-onset orthopedic complications, reduction in longevity, or reduction in fertility.</p><p><b>Males</b> with OPD1 present with the following:</p><ul><li class="half_rhythm"><div>A skeletal dysplasia manifest clinically by:</div><ul><li class="half_rhythm"><div>Digital anomalies including short, often proximally placed thumbs with hypoplasia of the distal phalanges. The distal phalanges of the other digits can also be hypoplastic with a squared (or "spatulate") disposition to the finger tips. The toes present a characteristic pattern of hypoplasia of the great toe, a long second toe, and a prominent sandal gap.</div></li><li class="half_rhythm"><div>Limitation of joint movement (elbow extension, wrist abduction) in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Limbs that may exhibit mild bowing</div></li><li class="half_rhythm"><div>Mildly reduced final height in some, although individuals have been characterized with pathogenic variants in <i>FLNA</i> and stature greater than the 90th percentile. Pubertal development and intelligence is normal in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</div></li></ul></li><li class="half_rhythm"><div>Characteristic facial features (prominent supraorbital ridges, downslanted palpebral fissures, widely spaced eyes, wide nasal bridge and broad nasal tip)</div></li><li class="half_rhythm"><div>Deafness (secondary either to ossicular malformation, neurosensory deficit, or a combination of both). The conductive hearing loss can be caused by fused and misshapen ossicles; attempts to separate the ossicles are usually unsuccessful and can lead to formation of a perilymphatic gusher.</div></li><li class="half_rhythm"><div>Cleft palate</div></li><li class="half_rhythm"><div>Oligohypodontia</div></li><li class="half_rhythm"><div>Normal intelligence</div></li></ul><p><b>Females</b> with OPD1 exhibit <a class="def" href="/books/n/gene/glossary/def-item/variable-expressivity/">variable expressivity</a>. Some females can manifest a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to that of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, related males. Females may develop conductive or neurosensory hearing loss. Note: One cannot confidently differentiate OPD1 from OPD2 in a single affected female in a family with no affected males [<a class="bk_pop" href="#opd.REF.moutton.2016.693">Moutton et al 2016</a>].</p></div><div id="opd.OPD2"><h4>OPD2</h4><p><b>Males</b> with OPD2 present with the following [<a class="bk_pop" href="#opd.REF.andr_.1981.747">Andr&#x000e9; et al 1981</a>, <a class="bk_pop" href="#opd.REF.fitch.1983.655">Fitch et al 1983</a>]:</p><ul><li class="half_rhythm"><div>A skeletal dysplasia manifest clinically as:</div><ul><li class="half_rhythm"><div>Thoracic hypoplasia</div></li><li class="half_rhythm"><div>Bowed long bones</div></li><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Digital anomalies (most commonly: hypoplasia of the first digit of the hands and feet or absent halluces, camptodactyly)</div></li><li class="half_rhythm"><div>Delayed closure of the fontanelles</div></li><li class="half_rhythm"><div>Scoliosis (occasional)</div></li></ul></li><li class="half_rhythm"><div>Characteristic craniofacial features similar to but more pronounced than those in OPD1. Pierre Robin sequence is commonly observed.</div></li><li class="half_rhythm"><div>Sensorineural and conductive deafness (common)</div></li><li class="half_rhythm"><div>Cardiac septal defects and obstructive lesions to the right ventricular outflow tract in some <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Associated omphalocele, hydronephrosis secondary to ureteric obstruction, and hypospadias [<a class="bk_pop" href="#opd.REF.young.1993.481">Young et al 1993</a>, <a class="bk_pop" href="#opd.REF.robertson.1997.341">Robertson et al 1997</a>]</div></li><li class="half_rhythm"><div>Central nervous system anomalies including hydrocephalus, cerebellar hypoplasia, and (rarely) encephalocele and meningomyelocele [<a class="bk_pop" href="#opd.REF.brewster.1985.249">Brewster et al 1985</a>, <a class="bk_pop" href="#opd.REF.stratton.1991.169">Stratton &#x00026; Bluestone 1991</a>]</div></li><li class="half_rhythm"><div>Developmental delay (common)</div></li><li class="half_rhythm"><div>Death commonly in the neonatal period as a result of respiratory insufficiency. Survival into the third year of life has been described with intensive medical treatment [<a class="bk_pop" href="#opd.REF.verloes.2000.407">Verloes et al 2000</a>].</div></li></ul><p><b>Females</b> with OPD2 usually present with a subclinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Characteristic craniofacial features (prominent supraorbital ridges, wide nasal bridge and a broad nasal tip) are the most common findings. Occasionally, conductive hearing loss has been described. Occasionally, females can manifest a phenotype similar in severity to that of males (craniofacial dysmorphism, cleft palate, conductive hearing loss, skeletal and digital anomalies). Note: One cannot confidently differentiate OPD1 from OPD2 in a single <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> female in a family with no affected males.</p></div><div id="opd.Frontometaphyseal_Dysplasia_Type_1"><h4>Frontometaphyseal Dysplasia Type 1</h4><p>Frontometaphyseal dysplasia type 1 (FMD1) shares many characteristics with OPD1, with some authors considering them the same condition [<a class="bk_pop" href="#opd.REF.supertifurga.1987.2">Superti-Furga &#x00026; Gimelli 1987</a>].</p><p><b>Males</b> with FMD1 present with the following:</p><ul><li class="half_rhythm"><div>A skeletal dysplasia manifest clinically as:</div><ul><li class="half_rhythm"><div>Distal phalangeal hypoplasia</div></li><li class="half_rhythm"><div>Progressive contractures of the hand over the first two decades resulting in marked limitation of movement at the interphalangeal and metacarpophalangeal joints</div></li><li class="half_rhythm"><div>Joint limitation at the wrists, elbows, knees, and ankles</div></li><li class="half_rhythm"><div>Scoliosis that may be progressive [<a class="bk_pop" href="#opd.REF.morava.2003.272">Morava et al 2003</a>]</div></li><li class="half_rhythm"><div>Limb bowing</div></li></ul></li><li class="half_rhythm"><div>Characteristic craniofacial features with very pronounced supraorbital hyperostosis, widely spaced eyes, and downslanted palpebral fissures [<a class="bk_pop" href="#opd.REF.gorlin.1969.487">Gorlin &#x00026; Cohen 1969</a>]. Craniosynostosis, an occasional finding, can evolve postnatally.</div></li><li class="half_rhythm"><div>Oligohypodontia (frequent)</div></li><li class="half_rhythm"><div>Conductive and sensorineural hearing loss in almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals</div></li><li class="half_rhythm"><div>Underdevelopment of the musculature, most notably around the shoulder girdle and in the intrinsic muscles of the hands (common)</div></li><li class="half_rhythm"><div>Extraskeletal anomalies including subglottic stenosis (which can present as <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> stridor [<a class="bk_pop" href="#opd.REF.leggett.1988.74">Leggett 1988</a>, <a class="bk_pop" href="#opd.REF.mehta.1988.505">Mehta &#x00026; Schou 1988</a>]), urethral stenosis, and hydronephrosis</div></li><li class="half_rhythm"><div>Cleft palate (rare)</div></li><li class="half_rhythm"><div>Normal intelligence</div></li></ul><p><b>Females</b> with FMD1 present with characteristic craniofacial features similar to those of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males [<a class="bk_pop" href="#opd.REF.gorlin.1980.81">Gorlin &#x00026; Winter 1980</a>]. The digital, subglottic, and urologic anomalies observed in males with FMD1 either do not occur in females or are observed in markedly attenuated form.</p></div><div id="opd.MelnickNeedles_Syndrome"><h4>Melnick-Needles Syndrome</h4><p>Substantial variability is observed in females. Some individuals are diagnosed in adulthood after ascertainment of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member [<a class="bk_pop" href="#opd.REF.kristiansen.2002.120">Kristiansen et al 2002</a>]. Others require substantial respiratory support; several individuals have required ambulatory oxygen supplementation, typically starting in the second decade. Longevity is reduced in these individuals.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of four males with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> known to lead to conventional MNS in females has been reported. These individuals have previously described skeletal (flexed upper limbs, hypoplastic thumbs, post-axial polydactyly, bowed lower limbs, clubfeet, kyphoscoliosis and hypoplastic halluces), craniofacial (large fontanelles, malar flattening, bilateral cleft palate, bifid tongue, severe micrognathia), and visceral (fibrosis of pancreas and spleen, bilateral cystic renal dysplasia secondary to obstructive uropathy and omphalocele) findings and unusual ophthalmologic signs (exophthalmia, widely spaced eyes, sclerocornea, cataracts, retinal angiomatosis, and a cleavage defect of the anterior chambers of both eyes) [<a class="bk_pop" href="#opd.REF.santos.2010.726">Santos et al 2010</a>, <a class="bk_pop" href="#opd.REF.naudion.2016.371">Naudion et al 2016</a>, <a class="bk_pop" href="#opd.REF.spencer.2018.980">Spencer et al 2018</a>].</p><p><b>Males</b> with MNS usually present with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> that is indistinguishable from, or more severe than, that associated with OPD2. Several women with classic MNS have had <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male pregnancies diagnosed in utero with a lethal phenotype reminiscent of a severe form of OPD2 [<a class="bk_pop" href="#opd.REF.santos.2010.726">Santos et al 2010</a>, <a class="bk_pop" href="#opd.REF.naudion.2016.371">Naudion et al 2016</a>, <a class="bk_pop" href="#opd.REF.spencer.2018.980">Spencer et al 2018</a>].</p><p><b>Females</b> with MNS present with the following:</p><ul><li class="half_rhythm"><div>A skeletal dysplasia characterized by:</div><ul><li class="half_rhythm"><div>Short stature</div></li><li class="half_rhythm"><div>Thoracic hypoplasia</div></li><li class="half_rhythm"><div>Limb bowing</div></li><li class="half_rhythm"><div>Joint subluxation</div></li><li class="half_rhythm"><div>Scoliosis</div></li><li class="half_rhythm"><div>Digits of both the hands and the feet that are typically long with mild distal phalangeal hypoplasia</div></li></ul></li><li class="half_rhythm"><div>Characteristic craniofacial features (prominent lateral margins of the supraorbital ridges, proptosis, full cheeks, micrognathia, facial asymmetry) [<a class="bk_pop" href="#opd.REF.foley.2010.121">Foley et al 2010</a>]</div></li><li class="half_rhythm"><div>Oligohypodontia (frequent)</div></li><li class="half_rhythm"><div>Sensorineural and conductive deafness (common)</div></li><li class="half_rhythm"><div>Hydronephrosis secondary to ureteric obstruction (common)</div></li><li class="half_rhythm"><div>Bleeding diathesis [<a class="bk_pop" href="#opd.REF.moutton.2016.693">Moutton et al 2016</a>]</div></li><li class="half_rhythm"><div>Normal intelligence</div></li><li class="half_rhythm"><div>Normal pubertal development</div></li></ul></div><div id="opd.Terminal_Osseous_Dysplasia_with_Pigm"><h4>Terminal Osseous Dysplasia with Pigmentary Defects</h4><p>The natural history for females with terminal osseous dysplasia with pigmentary skin defects (TODPD) has been documented in one large family [<a class="bk_pop" href="#opd.REF.brunettipierri.2010.1825">Brunetti-Pierri et al 2010</a>]. A male presentation of TODPD has never been described.</p><p><b>Females</b> exhibit pronounced abnormalities of the face, hands, and skin:</p><ul><li class="half_rhythm"><div>The major skeletal findings are in the hands. There is variable shortening, fusion, and disorganized ossification of the carpals and metacarpals. Camptodactyly can be marked and forms no clear pattern. Additional features include cystic lesions and bowing of the long bones, radial head dislocation, short stature, and scoliosis.</div></li><li class="half_rhythm"><div>Digital fibromata appear in infancy, can grow to a large size, and may re-grow after excision &#x02013; but eventually involute before age ten years.</div></li><li class="half_rhythm"><div>Cardiac septal defects</div></li><li class="half_rhythm"><div>Ureteric obstruction (occasional)</div></li><li class="half_rhythm"><div>Alopecia is a variable clinical finding.</div></li><li class="half_rhythm"><div>The most characteristic craniofacial findings are widely spaced eyes, oral frenulae, and punched out hyperpigmented lesions characteristically over the temporal region. Unlike the fibromata they do not involute with age.</div></li><li class="half_rhythm"><div>Normal intelligence</div></li><li class="half_rhythm"><div>A male presentation of TODPD has never been described and an excess of early miscarriage in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females has been recorded but not statistically verified.</div></li></ul></div></div><div id="opd.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Pathogenic variants associated with the X-OPD spectrum disorders are predicted to maintain the translational reading frame and to produce full-length protein. These variants are clustered in discrete regions of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>. Genotype-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation is strong. Two large studies have been published to date [<a class="bk_pop" href="#opd.REF.robertson.2006a.1726">Robertson et al 2006a</a>]:</p><ul><li class="half_rhythm"><div><b>OPD1.</b> All males with this diagnosis had pathogenic variants in exons 3, 4, or 5.</div></li><li class="half_rhythm"><div><b>OPD2.</b> All males with this diagnosis had pathogenic variants in exons 3, 4, or 5. Females with a <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> similar to males with typical OPD2 had pathogenic variants in exons 28 and 29.</div></li><li class="half_rhythm"><div><b>Frontometaphyseal dysplasia</b></div><ul><li class="half_rhythm"><div>Out of 13 males with FMD1, all had pathogenic variants in <i>FLNA</i> (exons 3-5, 22, 28-29) [<a class="bk_pop" href="#opd.REF.robertson.2006a.1726">Robertson et al 2006a</a>]. Pathogenic variants in females with FMD1 (found in 68% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> females) are more widely distributed over the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> (exons 3-5, 11, 22, 28-29, 41, 44-47) than pathogenic variants identified in males.</div></li><li class="half_rhythm"><div>One female with a combined FMD1-periventricular nodular heterotopia <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> had a <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variant that also created an ectopic <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> [<a class="bk_pop" href="#opd.REF.zenker.2004.731">Zenker et al 2004</a>].</div></li><li class="half_rhythm"><div>Some pathogenic variants are associated with a male-lethal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> caused by cardiac and urologic malformations [<a class="bk_pop" href="#opd.REF.stefanova.2005.386">Stefanova et al 2005</a>, <a class="bk_pop" href="#opd.REF.robertson.2006a.1726">Robertson et al 2006a</a>].</div></li></ul></li><li class="half_rhythm"><div><b>Melnick-Needles syndrome.</b> The vast majority (&#x0003e;90%) of individuals with MNS have pathogenic variants in <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> 22 of <i>FLNA,</i> with the two preponderant variants being <a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">p.Ala1188Thr</a> and <a class="figpopup" href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object" rid-figpopup="figopdTnotableflnapathogenicvariants" rid-ob="figobopdTnotableflnapathogenicvariants">p.Ser1199Leu</a>. Rare individuals have had pathogenic variants identified in exons 6 and 23.</div></li></ul></div><div id="opd.Penetrance"><h3>Penetrance</h3><p>Penetrance in males with an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> leading to an X-OPD spectrum disorder is complete.</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a> females with <i>FLNA</i> pathogenic variants leading to OPD1 have a normal clinical appearance. The proportion of <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females with radiographic features of OPD1 is unknown</p></div><div id="opd.Nomenclature"><h3>Nomenclature</h3><p>Melnick-Needles syndrome was originally referred to as osteodysplasty.</p><p>OPD1 was also called Taybi syndrome after its first description in 1963.</p><p><a class="bk_pop" href="#opd.REF.verloes.2000.407">Verloes et al [2000]</a> suggested the term "fronto-otopalatodigital osteodysplasia" for the X-OPD spectrum disorders, indicative of his prediction that they would prove allelic to one another, which subsequently proved correct. This term has not gained acceptance because some of these disorders are clinically discrete, and therefore diagnosis, management, and prognostication are not served by aggregating them under one term.</p></div><div id="opd.Prevalence"><h3>Prevalence</h3><p>No population-based studies have been performed to adequately assess prevalence.</p></div></div><div id="opd.Genetically_Related_Allelic_Disorder"><h2 id="_opd_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Other phenotypes associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>FLNA</i> are summarized in <a class="figpopup" href="/books/NBK1393/table/opd.T.features_of_xlinked_otopalatodigit/?report=objectonly" target="object" rid-figpopup="figopdTfeaturesofxlinkedotopalatodigit" rid-ob="figobopdTfeaturesofxlinkedotopalatodigit">Table 4</a>.</p><div id="opd.T.flna_allelic_disorders" class="table"><h3><span class="label">Table 5. </span></h3><div class="caption"><p><i>FLNA</i> Allelic Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.flna_allelic_disorders/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.flna_allelic_disorders_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.flna_allelic_disorders_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_opd.T.flna_allelic_disorders_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th><th id="hd_h_opd.T.flna_allelic_disorders_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">References</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Periventricular nodular heterotopia, <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> (X-PVNH)</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Neuronal migration disorder characterized by uncalcified nodules of neurons ectopically situated along the surface of the lateral ventricles</div></li><li class="half_rhythm"><div>Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> females; males show early lethality.</div></li><li class="half_rhythm"><div>Assoc w/gastrointestinal dysmotility</div></li><li class="half_rhythm"><div>1 female reported w/dual <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of PVNH &#x00026; FMD1</div></li></ul>
</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/x-pvh/"><i>FLNA</i>-Related Periventricular Nodular Heterotopia</a>, <a class="bk_pop" href="#opd.REF.zenker.2004.731">Zenker et al [2004]</a>, <a class="bk_pop" href="#opd.REF.hehr.2006.33">Hehr et al [2006]</a>, <a class="bk_pop" href="#opd.REF.gargiulo.2007.751">Gargiulo et al [2007]</a>, <a class="bk_pop" href="#opd.REF.kapur.2010.1528">Kapur et al [2010]</a></td></tr><tr><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Variant of <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> periventricular nodular heterotopia</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>PVNH w/marked connective tissue dysfunction (skin fragility, vascular dilatation) described in females &#x00026; males</div></li><li class="half_rhythm"><div>Assoc w/pathogenic variants predicted to &#x02192; loss of function</div></li></ul>
</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="bk_pop" href="#opd.REF.sheen.2005.254">Sheen et al [2005]</a>, <a class="bk_pop" href="#opd.REF.g_mezgarre.2006.232">G&#x000f3;mez-Garre et al [2006]</a>, <a class="bk_pop" href="#opd.REF.reinstein.2013.494">Reinstein et al [2013]</a></td></tr><tr><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Myxomatous cardiac valvular dystrophy</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Not assoc w/other neurologic or skeletal manifestations</div></li><li class="half_rhythm"><div>Of note, cardiac valvular anomalies are assoc w/X-PVNH &#x00026; some X-OPD spectrum disorders (e.g., FMD1).</div></li></ul>
</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/314400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">314400</a>, <a class="bk_pop" href="#opd.REF.kyndt.2007.1013">Kyndt et al [2007]</a>, <a class="bk_pop" href="#opd.REF.lardeux.2011.748">Lardeux et al [2011]</a></td></tr><tr><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Congenital intestinal obstruction, X linked</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gastrointestinal dysmotility is the prime manifestation if causative pathogenic variants lie in the 5' <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of an alternative transcript in the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a>.</td><td headers="hd_h_opd.T.flna_allelic_disorders_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">OMIM <a href="https://omim.org/entry/300048" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300048</a>, <a class="bk_pop" href="#opd.REF.kapur.2010.1528">Kapur et al [2010]</a>, <a class="bk_pop" href="#opd.REF.jenkins.2018.103">Jenkins et al [2018]</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FMD1 = frontometaphyseal dysplasia type 1; PVNH = periventricular nodular heterotopia; X-OPD = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital</p></div></dd></dl></div></div></div></div><div id="opd.Differential_Diagnosis"><h2 id="_opd_Differential_Diagnosis_">Differential Diagnosis</h2><div id="opd.T.other_genes_of_interest_in_the_dif" class="table"><h3><span class="label">Table 6. </span></h3><div class="caption"><p>Other Genes of Interest in the Differential Diagnosis of Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.other_genes_of_interest_in_the_dif/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.other_genes_of_interest_in_the_dif_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene</th><th id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" style="text-align:left;vertical-align:middle;">Disorder</th><th id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" style="text-align:left;vertical-align:middle;">MOI</th><th id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical Features of the Differential Diagnosis Disorder</th></tr><tr><th headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4" id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Overlapping w/X-OPD-SD</th><th headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4" id="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Differentiating from X-OPD-SD</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>AMER1</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Osteopathia striata congenita (OMIM <a href="https://omim.org/entry/300373" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">300373</a>)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">XL</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In males: similar skeletal dysplasia to that in OPD2; occasionally, extraskeletal anomalies similar to those in OPD2</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">In females: striations of the long bones, macrocephaly, &#x00026; deafness; in males: similar skeletal <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> to OPD2 in males</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>FLNB</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Larsen syndrome (LS) &#x00026; atelosteogenesis type III (AOIII) (see <a href="/books/n/gene/flnb-dis/"><i>FLNB</i>-Related Disorders</a>)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Similar facial features to those in OPD1 &#x00026; FMD1, cleft palate, hearing loss, spatulate fingers &#x00026; toes</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Large joint dislocations (in both LS &#x00026; AOIII) &#x00026; varying degrees of disordered ossification (in AOIII)</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>MAP3K7</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontometaphyseal dysplasia type 2</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very similar to FMD1</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very similar to FMD1, although individuals w/<i>MAP3K7</i>-FMD are more likely to have cleft palate, scoliosis, cervical fusions, hearing loss, &#x00026; keloid</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>NOTCH2</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Serpentine fibula-polycystic kidney disease (Hajdu-Cheney syndrome) (OMIM <a href="https://omim.org/entry/102500" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">102500</a>)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Bowing of long bones, especially fibula</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Acro-osteolysis, osteopenia, basilar indentation of the skull base. MNS does not incl cystic kidney disease.</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SH3PXD2B</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frank-ter Haar syndrome (OMIM <a href="https://omim.org/entry/249420" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">249420</a>)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AR</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal dysplasia similar to but considerably milder than in MNS</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Macrocornea w/or w/o glaucoma in Frank-ter Haar syndrome</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>SKI</i></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/books/n/gene/sgs/">Shprintzen-Goldberg syndrome</a> (SGS)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Skeletal dysplasia similar to MNS &#x00026; FMD1 (e.g., tall, square-shaped vertebrae; bowed tibiae; occasionally, fusion of upper cervical vertebrae)</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">ID &#x00026; craniosynostosis in SGS</td></tr><tr><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum1" rid-ob="figobopdTxlinkedotopalatodigitalspectrum1"><i>TAB2</i></a></td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frontometaphyseal dysplasia type 3</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">AD</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very similar to FMD1</td><td headers="hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_1_4 hd_h_opd.T.other_genes_of_interest_in_the_dif_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Very similar to FMD1, although individuals w/<a class="figpopup" href="/books/NBK1393/table/opd.T.xlinked_otopalatodigital_spectrum_1/?report=objectonly" target="object" rid-figpopup="figopdTxlinkedotopalatodigitalspectrum1" rid-ob="figobopdTxlinkedotopalatodigitalspectrum1"><i>TAB2</i></a>-FMD are more likely to have cleft palate, scoliosis, cervical fusions, hearing loss, &#x00026; keloid</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">AD = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a>; AR = <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a>; FMD = frontometaphyseal dysplasia; FMD1 = frontometaphyseal dysplasia type 1; ID = intellectual disability; MNS = Melnick-Needles syndrome; MOI = <a class="def" href="/books/n/gene/glossary/def-item/mode-of-inheritance/">mode of inheritance</a>; X-OPD-SD = <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital spectrum disorders; XL = X-linked</p></div></dd></dl></div></div></div><p><b>Possible <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> form of otopalatodigital syndrome type I.</b> A single report of a possible autosomal recessive phenocopy of otopalatodigital syndrome type I has been described but has not been subject to molecular analysis [<a class="bk_pop" href="#opd.REF.zaytoun.2002.129">Zaytoun et al 2002</a>]. The appearance of the facies and hands make this condition clinically quite distinct from the filaminopathies described here.</p></div><div id="opd.Management"><h2 id="_opd_Management_">Management</h2><div id="opd.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorder, the evaluations summarized in <a class="figpopup" href="/books/NBK1393/table/opd.T.other_genes_of_interest_in_the_dif/?report=objectonly" target="object" rid-figpopup="figopdTothergenesofinterestinthedif" rid-ob="figobopdTothergenesofinterestinthedif">Table 6</a> (if not performed as part of the evaluation that led to the diagnosis) are recommended.</p><div id="opd.T.recommended_evaluations_following" class="table"><h3><span class="label">Table 7. </span></h3><div class="caption"><p>Recommended Evaluations Following Initial Diagnosis in Individuals with X-Linked Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.recommended_evaluations_following/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.recommended_evaluations_following_lrgtbl__"><table><thead><tr><th id="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Musculoskeletal</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>Clinical examination of extremities, joints, &#x00026; spine</div></li><li class="half_rhythm"><div>Complete skeletal survey w/scoliosis series if indicated</div></li></ul>
</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for contractures, joint subluxations, scoliosis</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" rowspan="3" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniofacial</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical examination for facial or skull growth asymmetry</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for craniosynostosis</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Audiology evaluation</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for conduction &#x00026; sensorineural hearing loss</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Clinical examination of palate &#x00026; referral to ENT as necessary</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for cleft palate &#x00026; subglottic stenosis</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Respiratory</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Referral to pulmonologist if indicated</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for respiratory complications assoc w/thoracic hypoplasia</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Cardiac</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Echocardiogram</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for septal defects &#x00026; right ventricular outflow tract obstructive lesions</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Dental</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Dental evaluation</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for hypodontia, oligodontia</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Genitourinary</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Renal tract ultrasound examination</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">To evaluate for ureteric &#x00026; urethral obstruction &#x00026; hydronephrosis</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Ophthalmology</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical assessment for proptosis</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring for proptosis</td></tr><tr><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Other</b></td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Consultation w/clinical geneticist &#x00026;/or genetic counselor</td><td headers="hd_h_opd.T.recommended_evaluations_following_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr></tbody></table></div></div></div><div id="opd.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><div id="opd.T.treatment_of_manifestations_in_ind" class="table"><h3><span class="label">Table 8. </span></h3><div class="caption"><p>Treatment of Manifestations in Individuals with X-Linked Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.treatment_of_manifestations_in_ind/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.treatment_of_manifestations_in_ind_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Manifestation/Concern</th><th id="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Treatment</th><th id="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Considerations/Other</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Hand &#x00026; foot</b><br /><b>malformations</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical treatment may be required.</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Scoliosis</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Monitoring &#x00026; surgical intervention as required</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgery for scoliosis has had satisfactory results in several individuals.</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Contractures</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Physiotherapy</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Limb bowing</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgical correction of limb bowing has not been reported.</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Fronto-orbital</b><br /><b>deformity</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Cosmetic surgery</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Surgery attempted in some individuals; regrowth following surgery does not appear to occur [<a class="bk_pop" href="#opd.REF.kung.1998.1144">Kung &#x00026; Sloan 1998</a>].</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Thoracic hypoplasia</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chest expansion surgery</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Has been attempted in several individuals w/MNS w/marginal clinical benefit</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Apnea</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><ul><li class="half_rhythm"><div>CPAP [<a class="bk_pop" href="#opd.REF.lan.2006.77">Lan et al 2006</a>]</div></li><li class="half_rhythm"><div>Mandibular distraction</div></li></ul>
</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Micrognathia &#x00026; tracheobronchomalacia in severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals can &#x02192; airway collapse &#x00026; sleep apnea that have been successfully corrected in the most severe instances of MNS.</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Deafness</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Hearing aids</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Attempts to separate fused &#x00026; misshapen ossicles are usually unsuccessful &#x00026; can &#x02192; formation of a perilymphatic gusher.</td></tr><tr><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Laryngeal stenosis</b></td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation w/anesthesiology if intubation &#x00026; ventilation are required due to laryngeal stenosis</td><td headers="hd_h_opd.T.treatment_of_manifestations_in_ind_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Laryngeal stenosis rarely requires surgical intervention &#x00026; is non-progressive w/growth.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">CPAP = continuous positive airway pressure; MNS = Melnick-Needles syndrome</p></div></dd></dl></div></div></div></div><div id="opd.Surveillance"><h3>Surveillance</h3><div id="opd.T.recommended_surveillance_for_indiv" class="table"><h3><span class="label">Table 9. </span></h3><div class="caption"><p>Recommended Surveillance for Individuals with X-Linked Otopalatodigital Spectrum Disorders</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.recommended_surveillance_for_indiv/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.recommended_surveillance_for_indiv_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">System/Concern</th><th id="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Evaluation</th><th id="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Frequency</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Orthopedic</b><br /><b>manifestations</b></td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Clinical evaluation for development of:
<ul><li class="half_rhythm"><div>Hand contractures in FMD1</div></li><li class="half_rhythm"><div>Scoliosis in FMD1 &#x00026; MNS</div></li></ul>
</td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Annually</td></tr><tr><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Craniosynostosis</b></td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Head size &#x00026; shape should be monitored.</td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">W/each clinical evaluation during infancy</td></tr><tr><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Apnea</b></td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">History &#x00026;somnography studies as indicated</td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr><tr><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><b>Deafness</b></td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Audiology evaluations; sensorineural component can be progressive.</td><td headers="hd_h_opd.T.recommended_surveillance_for_indiv_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Yearly</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">FMD1 = Frontometaphyseal dysplasia type 1; MNS = Melnick-Needles syndrome</p></div></dd></dl></div></div></div></div><div id="opd.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to clarify the genetic status of apparently asymptomatic older and younger at-risk relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual in order to identify as early as possible those who would benefit from early evaluations for hearing loss and orthopedic complications, including scoliosis.</p><p>See <a href="#opd.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="opd.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="opd.Genetic_Counseling"><h2 id="_opd_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="opd.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorders &#x02013; otopalatodigital syndrome type 1 (OPD1), otopalatodigital syndrome type 2 (OPD2), frontometaphyseal dysplasia type 1 (FMD1), Melnick-Needles syndrome (MNS), and terminal osseous dysplasia with pigmentary skin defects (TODPD) &#x02013; are inherited in an X-linked manner.</p></div><div id="opd.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disorder nor will he be <a class="def" href="/books/n/gene/glossary/def-item/hemizygous/">hemizygous</a> for the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>In a family with more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual, the mother of an affected male is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-heterozygote/">obligate heterozygote</a>. Note: If a woman has more than one affected child and no other affected relatives and if the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in her leukocyte DNA, she most likely has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>. Germline mosaicism has been reported in X-OPD spectrum disorders [<a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al 2006b</a>].</div></li><li class="half_rhythm"><div>If a male is the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member (i.e., a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case), the mother may be a <a class="def" href="/books/n/gene/glossary/def-item/heterozygote/">heterozygote</a> (<a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>) or the affected male may have a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>
<i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, in which case the mother is not a carrier. <i>De novo</i> pathogenic variants are common in X-OPD spectrum disorders.</div></li></ul><p><b>Parents of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">A female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> may have inherited the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from either her mother or her father, or the pathogenic variant may be <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div class="half_rhythm">Detailed evaluation of the parents and review of the extended family history may help distinguish probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> from those with an inherited pathogenic variant. Molecular genetic testing of the mother (and possibly the father, or subsequently the father) can determine if the pathogenic variant was inherited.</div><div class="half_rhythm">Note: If a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s father is asymptomatic, it is possible that he has the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in some cells in his body (<a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a>). Somatic mosaicism for pathogenic variants leading to the X-OPD spectrum disorders has been described and has the potential to modify the expressivity of these disorders [<a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al 2006b</a>].</div></li></ul><p><b>Sibs of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the mother:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has a <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%.</div><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Note: Male sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with MNS or TODPD who inherit the pathogenic variant will be affected and generally die prenatally or perinatally.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be heterozygotes and have a range of clinical manifestations.</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al 2006b</a>].</div></li></ul><p><b>Sibs of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to sibs depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the mother of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the chance of transmitting it in each pregnancy is 50%.</div><ul><li class="half_rhythm"><div>Males who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>. Note: Male sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with MNS or TODPD who inherit the pathogenic variant will be affected and generally die prenatally or perinatally.</div></li><li class="half_rhythm"><div>Females who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be heterozygotes and have a range of clinical manifestations.</div></li></ul></li><li class="half_rhythm"><div>If the father of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> has an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, he will transmit it to all his daughters and none of his sons.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> represents a <a class="def" href="/books/n/gene/glossary/def-item/simplex/">simplex</a> case (i.e., a single occurrence in a family) and if the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of either parent, the <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> to sibs is slightly greater than that of the general population because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> [<a class="bk_pop" href="#opd.REF.robertson.2006b.549">Robertson et al 2006b</a>].</div></li></ul><p><b>Offspring of a male <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Males with OPD1 or FMD1 transmit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> to all of their daughters and none of their sons.</div></li><li class="half_rhythm"><div>Males with OPD2 do not reproduce.</div></li><li class="half_rhythm"><div>Males with MNS usually die in the pre- or perinatal period and do not reproduce.</div></li></ul><p><b>Offspring of a female <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Females who are <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have a 50% chance of transmitting the pathogenic variant to each child.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="opd.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#opd.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="opd.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p><b>Molecular genetic testing.</b> Once the <i>FLNA</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for an X-OPD spectrum disorder are possible.</p><p><b>Ultrasound examination.</b> Many of the manifestations of the disorder can be visualized prenatally by ultrasound examination, although the gestational age at which various anomalies can be detected differs. An omphalocele or urinary tract severely dilated by obstruction may be visible from very early in the second trimester. In contrast, the skeletal dysplasia with its associated limb bowing and thoracic hypoplasia may be visible only after 20 weeks' gestation [<a class="bk_pop" href="#opd.REF.naudion.2016.371">Naudion et al 2016</a>].</p><p>Note: Gestational age is expressed as menstrual weeks calculated either from the first day of the last normal menstrual period or by ultrasound measurements.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="opd.Resources"><h2 id="_opd_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>Alexander Graham Bell Association for the Deaf and Hard of Hearing</b></div><div>3417 Volta Place Northwest</div><div>Washington DC 20007</div><div><b>Phone:</b> 866-337-5220 (toll-free); 202-337-5220; 202-337-5221 (TTY)</div><div><b>Fax:</b> 202-337-8314</div><div><b>Email:</b> info@agbell.org</div><div><a href="http://www.agbell.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Listening and Spoken Language Knowledge Center</a></div></li><li class="half_rhythm"><div><b>American Society for Deaf Children (ASDC)</b></div><div>800 Florida Avenue Northeast</div><div>Suite 2047</div><div>Washington DC 20002-3695</div><div><b>Phone:</b> 800-942-2732 (Toll-free Parent Hotline); 866-895-4206 (toll free voice/TTY)</div><div><b>Fax:</b> 410-795-0965</div><div><b>Email:</b> info@deafchildren.org; asdc@deafchildren.org</div><div><a href="http://www.deafchildren.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.deafchildren.org</a></div></li><li class="half_rhythm"><div><b>Children's Craniofacial Association (CCA)</b></div><div>13140 Coit Road</div><div>Suite 517</div><div>Dallas TX 75240</div><div><b>Phone:</b> 800-535-3643 (toll-free)</div><div><b>Email:</b> contactCCA@ccakids.com</div><div><a href="https://ccakids.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ccakids.org</a></div></li><li class="half_rhythm"><div><b>Face Equality International</b></div><div>United Kingdom</div><div><b>Email:</b> info@faceequalityinternational.org</div><div><a href="https://faceequalityinternational.org/thealliance/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faceequalityinternational.org</a></div></li><li class="half_rhythm"><div><b>FACES: The National Craniofacial Association</b></div><div>PO Box 11082</div><div>Chattanooga TN 37401</div><div><b>Phone:</b> 800-332-2373 (toll-free)</div><div><b>Email:</b> faces@faces-cranio.org</div><div><a href="http://www.faces-cranio.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.faces-cranio.org</a></div></li><li class="half_rhythm"><div><b>Human Growth Foundation (HGF)</b></div><div>997 Glen Cove Avenue</div><div>Suite 5</div><div>Glen Head NY 11545</div><div><b>Phone:</b> 800-451-6434 (toll-free)</div><div><b>Fax:</b> 516-671-4055</div><div><b>Email:</b> hgf1@hgfound.org</div><div><a href="http://www.hgfound.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.hgfound.org</a></div></li><li class="half_rhythm"><div><b>MAGIC Foundation</b></div><div>4200 Cantera Drive #106</div><div>Warrenville IL 60555</div><div><b>Phone:</b> 800-362-4423 (Toll-free Parent Help Line); 630-836-8200</div><div><b>Fax:</b> 630-836-8181</div><div><b>Email:</b> contactus@magicfoundation.org</div><div><a href="http://www.magicfoundation.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.magicfoundation.org</a></div></li><li class="half_rhythm"><div><b>National Association of the Deaf (NAD)</b></div><div>8630 Fenton Street</div><div>Suite 820</div><div>Silver Spring MD 20910</div><div><b>Phone:</b> 301-587-1788; 301-587-1789 (TTY)</div><div><b>Fax:</b> 301-587-1791</div><div><b>Email:</b> nad.info@nad.org</div><div><a href="http://www.nad.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.nad.org</a></div></li></ul></div><div id="opd.Molecular_Genetics"><h2 id="_opd_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="opd.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>X-Linked Otopalatodigital Spectrum Disorders: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_opd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_opd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_opd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_opd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_opd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_opd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_opd.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/2316" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>FLNA</i></a></td><td headers="hd_b_opd.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=2316" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq28</a></td><td headers="hd_b_opd.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P21333" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Filamin-A</a></td><td headers="hd_b_opd.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.LOVD.nl/FLNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA @ LOVD</a></td><td headers="hd_b_opd.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=FLNA" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA</a></td><td headers="hd_b_opd.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=FLNA[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">FLNA</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="opd.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="opd.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for X-Linked Otopalatodigital Spectrum Disorders (<a href="/omim/300017,304120,305620,309350,311300" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300017" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300017</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FILAMIN A; FLNA</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/304120" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">304120</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OTOPALATODIGITAL SYNDROME, TYPE II; OPD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/305620" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">305620</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">FRONTOMETAPHYSEAL DYSPLASIA 1; FMD1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/309350" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">309350</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MELNICK-NEEDLES SYNDROME; MNS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/311300" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">311300</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">OTOPALATODIGITAL SYNDROME, TYPE I; OPD1</td></tr></tbody></table></div></div><div id="opd.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p><i>FLNA</i> encodes filamin A, a member of the class of actin-binding proteins that regulate cell stability, protrusion, and motility across various organisms [<a class="bk_pop" href="#opd.REF.gorlin.1990.1089">Gorlin et al 1990</a>, <a class="bk_pop" href="#opd.REF.cunningham.1992.325">Cunningham et al 1992</a>]. Filamins coordinate and integrate cell signaling and subsequent remodeling of the actin cytoskeleton. Filamin associates with integrins, which regulate such cellular processes as cell adhesion and neuronal migration [<a class="bk_pop" href="#opd.REF.meyer.1997.81">Meyer et al 1997</a>, <a class="bk_pop" href="#opd.REF.loo.1998.23304">Loo et al 1998</a>, <a class="bk_pop" href="#opd.REF.dulabon.2000.33">Dulabon et al 2000</a>]. The complexity of these interactions makes the implication of individual functions in the pathogenesis of these conditions difficult. Structural mechanisms that change the topology of filamin in such circumstances &#x02013; and possibly alter binding interactions or post-translational modification of filamin as a result &#x02013; have been described.</p><p>Filamin A may influence neuroprogenitor differentiation and migration during cortical development within the central nervous system via its interaction with the cytoskeleton. Disruption of this process could result in the formation of periventricular heterotopia [<a class="bk_pop" href="#opd.REF.carabalona.2012.1004">Carabalona et al 2012</a>]. Similarly, filamins regulate signal transduction by transmembrane receptors and second messengers, the disruption of which could lead to developmental defects such as those observed in the <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> otopalatodigital (X-OPD) spectrum disorder phenotypes.</p><p><b>Mechanism of disease causation.</b> The mechanism of disease for <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> variants (leading to periventricular nodular heterotopia) and of the clustered pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants (leading to the X-OPD spectrum disorders) are not fully understood.</p><p>This clustered distribution of pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that lead to the X-OPD spectrum disorders indicates that very specific functions of filamins are being altered. Interactions with filamin or localized domains of filamin that have regulatory functions may be altered by these pathogenic variants. Some missense variants enhance the affinity of filamin A for binding actin [<a class="bk_pop" href="#opd.REF.clark.2009.4791">Clark et al 2009</a>] while others alter the mechanically sensitive properties of filamin [<a class="bk_pop" href="#opd.REF.ithychanda.2017.8390">Ithychanda et al 2017</a>].</p><div id="opd.T.notable_flna_pathogenic_variants" class="table"><h3><span class="label">Table 10. </span></h3><div class="caption"><p>Notable <i>FLNA</i> Pathogenic Variants</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1393/table/opd.T.notable_flna_pathogenic_variants/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__opd.T.notable_flna_pathogenic_variants_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th><th id="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_4" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Comment</th></tr></thead><tbody><tr><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_1" rowspan="4" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/160420316" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_001110556<wbr style="display:inline-block"></wbr>​.1</a><br /><a href="/protein/160420317" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001104026<wbr style="display:inline-block"></wbr>​.1</a></td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.3552C&#x0003e;A</td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Asp1184Glu</td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_4" rowspan="3" colspan="1" style="text-align:left;vertical-align:middle;">Melnick-Needles syndrome</td></tr><tr><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3562G&#x0003e;A</td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ala1188Thr</td></tr><tr><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.3596C&#x0003e;T</td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Ser1199Leu</td></tr><tr><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">c.5217G&#x0003e;A&#x000a0;<sup>1</sup></td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val1724_Thr1739del</td><td headers="hd_h_opd.T.notable_flna_pathogenic_variants_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Terminal osseous dysplasia w/pigmentary skin defects</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Variants listed in the table have been provided by the author. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin"><i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd><dt>1. </dt><dd><div id="opd.TF.10.1"><p class="no_margin">This variant occurs at the last base of an <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and is predicted to cause no amino acid change but does affect <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> resulting in <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of 16 amino acids [<a class="bk_pop" href="#opd.REF.sun.2010.146">Sun et al 2010</a>].</p></div></dd></dl></div></div></div></div></div><div id="opd.References"><h2 id="_opd_References_">References</h2><div id="opd.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="opd.REF.andr_.1981.747">Andr&#x000e9; M, Vigneron J, Didier F. Abnormal facies, cleft palate, and generalized dysostosis: a lethal X-linked syndrome. <span><span class="ref-journal">J Pediatr. </span>1981;<span class="ref-vol">98</span>:747–52.</span> [<a href="/pubmed/7229752" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7229752</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.brewster.1985.249">Brewster TG, Lachman RS, Kushner DC, Holmes LB, Isler RJ, Rimoin DL. Oto-palato-digital syndrome, type II &#x02014; an X-linked skeletal dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>1985;<span class="ref-vol">20</span>:249–54.</span> [<a href="/pubmed/3976718" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3976718</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.brunettipierri.2010.1825">Brunetti-Pierri N, Lachman R, Lee K, Leal SM, Piccolo P, Van Den Veyver IB, Bacino CA. Terminal osseous dysplasia with pigmentary defects (TODPD): Follow-up of the first reported family, characterization of the radiological phenotype, and refinement of the linkage region. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:1825–31.</span> [<a href="/pmc/articles/PMC2909110/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2909110</span></a>] [<a href="/pubmed/20583181" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20583181</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.carabalona.2012.1004">Carabalona A, Beguin S, Pallesi-Pocachard E, Buhler E, Pellegrino C, Arnaud K, Hubert P, Oualha M, Siffroi JP, Khantane S, Coupry I, Goizet C, Gelot AB, Represa A, Cardoso C. A glial origin for periventricular nodular heterotopia caused by impaired expression of Filamin-A. <span><span class="ref-journal">Hum Mol Genet. </span>2012;<span class="ref-vol">21</span>:1004–17.</span> [<a href="/pubmed/22076441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22076441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.clark.2009.4791">Clark AR, Sawyer GM, Robertson SP, Sutherland-Smith AJ. Skeletal dysplasias due to filamin A mutations result from a gain-of-function mechanism distinct from allelic neurological disorders. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:4791–800.</span> [<a href="/pubmed/19773341" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19773341</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.cunningham.1992.325">Cunningham CC, Gorlin JB, Kwiatkowski DJ, Hartwig JH, Janmey PA, Byers HR, Stossel TP. Actin-binding protein requirement for cortical stability and efficient locomotion. <span><span class="ref-journal">Science. </span>1992;<span class="ref-vol">255</span>:325–7.</span> [<a href="/pubmed/1549777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1549777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.dulabon.2000.33">Dulabon L, Olson EC, Taglienti MG, Eisenhuth S, McGrath B, Walsh CA, Kreidberg JA, Anton ES. Reelin binds alpha3beta1 integrin and inhibits neuronal migration. <span><span class="ref-journal">Neuron. </span>2000;<span class="ref-vol">27</span>:33–44.</span> [<a href="/pubmed/10939329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10939329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.fitch.1983.655">Fitch N, Jequier S, Gorlin R. The oto-palato-digital syndrome, proposed type II. <span><span class="ref-journal">Am J Med Genet. </span>1983;<span class="ref-vol">15</span>:655–64.</span> [<a href="/pubmed/6614053" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6614053</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.foley.2010.121">Foley C, Roberts K, Tchrakian N, Morgan T, Fryer A, Robertson SP, Tubridy N. Expansion of the spectrum of FLNA mutations associated with Melnick-Needles syndrome. <span><span class="ref-journal">Mol Syndromol. </span>2010;<span class="ref-vol">1</span>:121–6.</span> [<a href="/pmc/articles/PMC2957847/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2957847</span></a>] [<a href="/pubmed/21031081" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21031081</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.gargiulo.2007.751">Gargiulo A, Auricchio R, Barone MV, Cotugno G, Reardon W, Milla PJ, Ballabio A, Ciccodicola A, Auricchio A. Filamin A is mutated in X-linked chronic idiopathic intestinal pseudo-obstruction with central nervous system involvement. <span><span class="ref-journal">Am J Hum Genet. </span>2007;<span class="ref-vol">80</span>:751–8.</span> [<a href="/pmc/articles/PMC1852717/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1852717</span></a>] [<a href="/pubmed/17357080" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17357080</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.g_mezgarre.2006.232">G&#x000f3;mez-Garre P, Seijo M, Guti&#x000e9;rrez-Delicado E, Castro del R&#x000ed;o M, de la Torre C, G&#x000f3;mez-Abad C, Morales-Corraliza J, Puig M, Serratosa JM. Ehlers-Danlos syndrome and periventricular nodular heterotopia in a Spanish family with a single FLNA mutation. <span><span class="ref-journal">J Med Genet. </span>2006;<span class="ref-vol">43</span>:232–7.</span> [<a href="/pmc/articles/PMC2563248/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2563248</span></a>] [<a href="/pubmed/15994863" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15994863</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.gorlin.1990.1089">Gorlin JB, Yamin R, Egan S, Stewart M, Stossel TP, Kwiatkowski DJ, Hartwig JH. Human endothelial actin-binding protein (ABP-280, nonmuscle filamin): a molecular leaf spring. <span><span class="ref-journal">J Cell Biol. </span>1990;<span class="ref-vol">111</span>:1089–105.</span> [<a href="/pmc/articles/PMC2116286/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2116286</span></a>] [<a href="/pubmed/2391361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2391361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.gorlin.1969.487">Gorlin RJ, Cohen MM Jr. Frontometaphyseal dysplasia. A new syndrome. <span><span class="ref-journal">Am J Dis Child. </span>1969;<span class="ref-vol">118</span>:487–94.</span> [<a href="/pubmed/5807657" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5807657</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.gorlin.1980.81">Gorlin RJ, Winter RB. Frontometaphyseal dysplasia &#x02014; evidence for X-linked inheritance. <span><span class="ref-journal">Am J Med Genet. </span>1980;<span class="ref-vol">5</span>:81–4.</span> [<a href="/pubmed/7395904" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7395904</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.gorlin.1973.218">Gorlin RJ, Poznanski AK, Hendon I. The oto-palato-digital (OPD) syndrome in females. <span><span class="ref-journal">Oral Surg Oral Med Oral Pathol. </span>1973;<span class="ref-vol">35</span>:218–24.</span> [<a href="/pubmed/4513067" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 4513067</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.hehr.2006.33">Hehr T, Classen J, Welz S, Ganswindt U, Scheithauer H, Koitschev A, Bamberg M, Budach W. Hyperfractionated, accelerated chemoradiation with concurrent mitomycin-C and cisplatin in locally advanced head and neck cancer, a phase I/II study. <span><span class="ref-journal">Radiother Oncol. </span>2006;<span class="ref-vol">80</span>:33–8.</span> [<a href="/pubmed/16875750" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16875750</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.ithychanda.2017.8390">Ithychanda SS, Dou K, Robertson SP, Qin J. Structural and thermodynamic basis of a frontometaphyseal dysplasia mutation in filamin A. <span><span class="ref-journal">J Biol Chem. </span>2017;<span class="ref-vol">292</span>:8390–400.</span> [<a href="/pmc/articles/PMC5437244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5437244</span></a>] [<a href="/pubmed/28348077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 28348077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.jenkins.2018.103">Jenkins ZA, Macharg A, Chang CY, van Kogelenberg M, Morgan T, Frentz S, Wei W, Pilch J, Hannibal M, Foulds N, McGillivray G, Leventer RJ, Garc&#x000ed;a-Mi&#x000f1;a&#x000fa;r S, Sugito S, Nightingale S, Markie DM, Dudding T, Kapur RP, Robertson SP. Differential regulation of two FLNA transcripts explains some of the phenotypic heterogeneity in the loss-of-function filaminopathies. <span><span class="ref-journal">Hum Mutat. </span>2018;<span class="ref-vol">39</span>:103–13.</span> [<a href="/pubmed/29024177" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29024177</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.kapur.2010.1528">Kapur RP, Robertson SP, Hannibal MC, Finn LS, Morgan T, van Kogelenberg M, Loren DJ. Diffuse abnormal layering of small intestinal smooth muscle is present in patients with FLNA mutations and X-linked intestinal pseudo-obstruction. <span><span class="ref-journal">Am J Surg Pathol. </span>2010;<span class="ref-vol">34</span>:1528–43.</span> [<a href="/pubmed/20871226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20871226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.kristiansen.2002.120">Kristiansen M, Knudsen GP, Soyland A, Westvik J, Orstavik KH. Phenotypic variation in Melnick-Needles syndrome is not reflected in X inactivation patterns from blood or buccal smear. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:120–7.</span> [<a href="/pubmed/11857561" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11857561</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.kung.1998.1144">Kung DS, Sloan GM. Cranioplasty in frontometaphyseal dysplasia. <span><span class="ref-journal">Plast Reconstr Surg. </span>1998;<span class="ref-vol">102</span>:1144–6.</span> [<a href="/pubmed/9734434" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9734434</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.kyndt.2007.1013">Kyndt F, Le Scouarnec S, Jaafar P, Gueffet JP, Legendre A, Trochu JN, Jousseaume V, Chaventr&#x000e9; A, Schott JJ, Le Marec H, Probst V. Genetic aspects of valvulopathies. <span><span class="ref-journal">Arch Mal Coeur Vaiss. </span>2007;<span class="ref-vol">100</span>:1013–20.</span> [<a href="/pubmed/18223515" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18223515</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.lan.2006.77">Lan CC, Hung KF, Liao YF, Lin SW, Chen NH. Melnick-Needles syndrome with obstructive sleep apnea successfully treated with nasal continuous positive airway pressure ventilation. <span><span class="ref-journal">J Formos Med Assoc. </span>2006;<span class="ref-vol">105</span>:77–9.</span> [<a href="/pubmed/16440074" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16440074</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.lardeux.2011.748">Lardeux A, Kyndt F, Lecointe S, Marec HL, Merot J, Schott JJ, Le Tourneau T, Probst V. Filamin-a-related myxomatous mitral valve dystrophy: genetic, echocardiographic and functional aspects. <span><span class="ref-journal">J Cardiovasc Transl Res. </span>2011;<span class="ref-vol">4</span>:748–56.</span> [<a href="/pubmed/21773876" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21773876</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.leggett.1988.74">Leggett JM. Laryngo-tracheal stenosis in frontometaphyseal dysplasia. <span><span class="ref-journal">J Laryngol Otol. </span>1988;<span class="ref-vol">102</span>:74–8.</span> [<a href="/pubmed/3343570" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3343570</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.loo.1998.23304">Loo DT, Kanner SB, Aruffo A. Filamin binds to the cytoplasmic domain of the beta1-integrin. Identification of amino acids responsible for this interaction. <span><span class="ref-journal">J Biol Chem. </span>1998;<span class="ref-vol">273</span>:23304–12.</span> [<a href="/pubmed/9722563" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9722563</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.mehta.1988.505">Mehta Y, Schou H. The anaesthetic management of an infant with frontometaphyseal dysplasia (Gorlin-Cohen syndrome). <span><span class="ref-journal">Acta Anaesthesiol Scand. </span>1988;<span class="ref-vol">32</span>:505–7.</span> [<a href="/pubmed/3176838" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3176838</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.meyer.1997.81">Meyer U, Meyer T, Jones DB. No mechanical role for vinculin in strain transduction in primary bovine osteoblasts. <span><span class="ref-journal">Biochem Cell Biol. </span>1997;<span class="ref-vol">75</span>:81–7.</span> [<a href="/pubmed/9192077" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9192077</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.morava.2003.272">Morava E, Ill&#x000e9;s T, Weisenbach J, K&#x000e1;rteszi J, Kosztol&#x000e1;nyi G. Clinical and genetic heterogeneity in frontometaphyseal dysplasia: severe progressive scoliosis in two families. <span><span class="ref-journal">Am J Med Genet A. </span>2003;<span class="ref-vol">116A</span>:272–7.</span> [<a href="/pubmed/12503106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12503106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.moutton.2016.693">Moutton S, Fergelot P, Naudion S, Cordier MP, Sol&#x000e9; G, Guerineau E, Hubert C, Rooryck C, Vuillaume ML, Houcinat N, Deforges J, Bouron J, Dev&#x000e8;s S, Le Merrer M, David A, Genevi&#x000e8;ve D, Giuliano F, Journel H, Megarbane A, Faivre L, Chassaing N, Francannet C, Sarrazin E, Stattin EL, Vigneron J, Leclair D, Abadie C, Sarda P, Baumann C, Delrue MA, Arveiler B, Lacombe D, Goizet C, Coupry I. Otopalatodigital spectrum disorders: refinement of the phenotypic and mutational spectrum. <span><span class="ref-journal">J Hum Genet. </span>2016;<span class="ref-vol">61</span>:693–9.</span> [<a href="/pubmed/27193221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27193221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.naudion.2016.371">Naudion S, Moutton S, Coupry I, Sole G, Deforges J, Guerineau E, Hubert C, Deves S, Pilliod J, Rooryck C, Abel C, Le Breton F, Collardeau-Frachon S, Cordier MP, Delezoide AL, Goldenberg A, Loget P, Melki J, Odent S, Patrier S, Verloes A, Viot G, Blesson S, Bessi&#x000e8;res B, Lacombe D, Arveiler B, Goizet C, Fergelot P. Fetal phenotypes in otopalatodigital spectrum disorders. <span><span class="ref-journal">Clin Genet. </span>2016;<span class="ref-vol">89</span>:371–7.</span> [<a href="/pubmed/26404489" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 26404489</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.reinstein.2013.494">Reinstein E, Frentz S, Morgan T, Garc&#x000ed;a-Mi&#x000f1;a&#x000fa;r S, Leventer RJ, McGillivray G, Pariani M, van der Steen A, Pope M, Holder-Espinasse M, Scott R, Thompson EM, Robertson T, Coppin B, Siegel R, Bret Zurita M, Rodr&#x000ed;guez JI, Morales C, Rodrigues Y, Arcas J, Saggar A, Horton M, Zackai E, Graham JM, Rimoin DL, Robertson SP. Vascular and connective tissue anomalies associated with X-linked periventricular heterotopia due to mutations in Filamin A. <span><span class="ref-journal">Eur J Hum Genet. </span>2013;<span class="ref-vol">21</span>:494–502.</span> [<a href="/pmc/articles/PMC3641385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3641385</span></a>] [<a href="/pubmed/23032111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23032111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.robertson.1997.341">Robertson S, Gunn T, Allen B, Chapman C, Becroft D. Are Melnick-Needles syndrome and oto-palato-digital syndrome type II allelic? Observations in a four-generation kindred. <span><span class="ref-journal">Am J Med Genet. </span>1997;<span class="ref-vol">71</span>:341–7.</span> [<a href="/pubmed/9268106" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9268106</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.robertson.2006a.1726">Robertson SP, Jenkins ZA, Morgan T, Ad&#x000e8;s LA, Aftimos S, Boute O, Fiskerstrand T, Garcia-Min&#x000e3;ur S, Grix A, Green A, Der Kaloustian V, Lewkonia R, McInnes B, van Haelst MM, Mancini G, Ill&#x000e9;s T, Mortier G, Newbury-Ecob R, Nicholson L, Scott CI, Ochman K, Bro&#x0017c;ek I, Shears DJ, Superti-Furga A, Suri M, Whiteford M, Wilkie AO, Krakow D. Frontometaphyseal dysplasia: mutations in FLNA and phenotypic diversity. <span><span class="ref-journal">Am J Med Genet A. </span>2006a;<span class="ref-vol">140</span>:1726–36.</span> [<a href="/pubmed/16835913" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16835913</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.robertson.2006b.549">Robertson SP, Thompson S, Morgan T, Holder-Espinasse M, Martinot-Duquenoy V, Wilkie AO, Manouvrier-Hanu S. Postzygotic mutation and germline mosaicism in the otopalatodigital syndrome spectrum disorders. <span><span class="ref-journal">Eur J Hum Genet. </span>2006b;<span class="ref-vol">14</span>:549–54.</span> [<a href="/pubmed/16538226" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16538226</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.robertson.2003.487">Robertson SP, Twigg SR, Sutherland-Smith AJ, Biancalana V, Gorlin RJ, Horn D, Kenwrick SJ, Kim CA, Morava E, Newbury-Ecob R, Orstavik KH, Quarrell OW, Schwartz CE, Shears DJ, Suri M, Kendrick-Jones J, Wilkie AO, et al.  Localized mutations in the gene encoding the cytoskeletal protein filamin A cause diverse malformations in humans. <span><span class="ref-journal">Nat Genet. </span>2003;<span class="ref-vol">33</span>:487–91.</span> [<a href="/pubmed/12612583" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12612583</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.santos.2010.726">Santos HH, Garcia PP, Pereira L, Le&#x000e3;o LL, Aguiar RA, Lana AM, Carvalho MR, Aguiar MJ. Mutational analysis of two boys with the severe perinatally lethal Melnick-Needles syndrome. <span><span class="ref-journal">Am J Med Genet A. </span>2010;<span class="ref-vol">152A</span>:726–31.</span> [<a href="/pubmed/20186808" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20186808</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.sheen.2005.254">Sheen VL, Jansen A, Chen MH, Parrini E, Morgan T, Ravenscroft R, Ganesh V, Underwood T, Wiley J, Leventer R, Vaid RR, Ruiz DE, Hutchins GM, Menasha J, Willner J, Geng Y, Gripp KW, Nicholson L, Berry-Kravis E, Bodell A, Apse K, Hill RS, Dubeau F, Andermann F, Barkovich J, Andermann E, Shugart YY, Thomas P, Viri M, Veggiotti P, Robertson S, Guerrini R, Walsh CA. Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. <span><span class="ref-journal">Neurology. </span>2005;<span class="ref-vol">64</span>:254–62.</span> [<a href="/pubmed/15668422" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15668422</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.spencer.2018.980">Spencer C, Lombaard H, Wise A, Krause A, Robertson SP. A recurrent mutation causing Melnick-Needles syndrome in females confers a severe, lethal phenotype in males. <span><span class="ref-journal">Am J Med Genet A. </span>2018;<span class="ref-vol">176</span>:980–4.</span> [<a href="/pubmed/29575627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 29575627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.stefanova.2005.386">Stefanova M, Meinecke P, Gal A, Bolz H. A novel 9 bp deletion in the filamin a gene causes an otopalatodigital-spectrum disorder with a variable, intermediate phenotype. <span><span class="ref-journal">Am J Med Genet A. </span>2005;<span class="ref-vol">132A</span>:386–90.</span> [<a href="/pubmed/15654694" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15654694</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.stratton.1991.169">Stratton RF, Bluestone DL. Oto-palatal-digital syndrome type II with X-linked cerebellar hypoplasia/hydrocephalus. <span><span class="ref-journal">Am J Med Genet. </span>1991;<span class="ref-vol">41</span>:169–72.</span> [<a href="/pubmed/1785627" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1785627</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.sun.2010.146">Sun Y, Almomani R, Aten E, Celli J, van der Heijden J, Venselaar H, Robertson SP, Baroncini A, Franco B, Basel-Vanagaite L, Horii E, Drut R, Ariyurek Y, den Dunnen JT, Breuning MH. Terminal osseous dysplasia is caused by a single recurrent mutation in the FLNA gene. <span><span class="ref-journal">Am J Hum Genet. </span>2010;<span class="ref-vol">87</span>:146–53.</span> [<a href="/pmc/articles/PMC2896768/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2896768</span></a>] [<a href="/pubmed/20598277" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20598277</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.supertifurga.1987.2">Superti-Furga A, Gimelli F. Fronto-metaphyseal dysplasia and the oto-palato-digital syndrome. <span><span class="ref-journal">Dysmorph Clin Genet. </span>1987;<span class="ref-vol">1</span>:2–5.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.verloes.2000.407">Verloes A, Lesenfants S, Barr M, Grange DK, Journel H, Lombet J, Mortier G, Roeder E. Fronto-otopalatodigital osteodysplasia: clinical evidence for a single entity encompassing Melnick-Needles syndrome, otopalatodigital syndrome types 1 and 2, and frontometaphyseal dysplasia. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">90</span>:407–22.</span> [<a href="/pubmed/10706363" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10706363</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.wade.2016.392">Wade EM, Daniel PB, Jenkins ZA, McInerney-Leo A, Leo P, Morgan T, Addor MC, Ad&#x000e8;s LC, Bertola D, Bohring A, Carter E, Cho TJ, Duba HC, Fletcher E, Kim CA, Krakow D, Morava E, Neuhann T, Superti-Furga A, Veenstra-Knol I, Wieczorek D, Wilson LC, Hennekam RC, Sutherland-Smith AJ, Strom TM, Wilkie AO, Brown MA, Duncan EL, Markie DM, Robertson SP. Mutations in MAP3K7 that alter the activity of the TAK1 signaling complex cause frontometaphyseal dysplasia. <span><span class="ref-journal">Am J Hum Genet. </span>2016;<span class="ref-vol">99</span>:392–406.</span> [<a href="/pmc/articles/PMC4974064/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4974064</span></a>] [<a href="/pubmed/27426733" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 27426733</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.young.1993.481">Young K, Barth CK, Moore C, Weaver DD. Otopalatodigital syndrome type II associated with omphalocele: report of three cases. <span><span class="ref-journal">Am J Med Genet. </span>1993;<span class="ref-vol">45</span>:481–7.</span> [<a href="/pubmed/8465856" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8465856</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.zaytoun.2002.129">Zaytoun GM, Harboyan G, Kabalan W. The oto-palato-digital syndrome: variable clinical expressions. <span><span class="ref-journal">Otolaryngol Head Neck Surg. </span>2002;<span class="ref-vol">126</span>:129–40.</span> [<a href="/pubmed/11870342" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11870342</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="opd.REF.zenker.2004.731">Zenker M, Rauch A, Winterpacht A, Tagariello A, Kraus C, Rupprecht T, Sticht H, Reis A. A dual phenotype of periventricular nodular heterotopia and frontometaphyseal dysplasia in one patient caused by a single FLNA mutation leading to two functionally different aberrant transcripts. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">74</span>:731–7.</span> [<a href="/pmc/articles/PMC1181949/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1181949</span></a>] [<a href="/pubmed/14988809" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14988809</span></a>]</div></li></ul></div></div><div id="opd.Chapter_Notes"><h2 id="_opd_Chapter_Notes_">Chapter Notes</h2><div id="opd.Acknowledgments"><h3>Acknowledgments</h3><p>The author is supported by Curekids New Zealand.</p></div><div id="opd.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 October 2019 (sw) Comprehensive update posted live</div></li><li class="half_rhythm"><div>2 May 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>28 April 2009 (cd) Revision: Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis available clinically</div></li><li class="half_rhythm"><div>25 July 2008 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>30 November 2005 (me) Review posted live</div></li><li class="half_rhythm"><div>14 March 2005 (sr) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1393</span><span class="label">PMID: <a href="/pubmed/20301567" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301567</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/opitz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/epp-xl/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1393&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1393/?report=reader">PubReader</a></li><li><a href="/books/NBK1393/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1393" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1393" style="display:none" title="Cite this Page"><div class="bk_tt">Robertson S. X-Linked Otopalatodigital Spectrum Disorders. 2005 Nov 30 [Updated 2019 Oct 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1393/pdf/Bookshelf_NBK1393.pdf">PDF version of this page</a> (537K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#opd.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#opd.GeneReview_Scope" ref="log$=inpage&amp;link_id=inpage"><i>GeneReview</i> Scope</a></li><li><a href="#opd.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#opd.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#opd.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#opd.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#opd.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#opd.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#opd.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#opd.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#opd.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#opd.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=2316[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">FLNA</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK1393+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1481052" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1481052" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1481052" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1481052" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26404489" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Fetal phenotypes in otopalatodigital spectrum disorders.</a><span class="source">[Clin Genet. 2016]</span><div class="brieflinkpop offscreen_noflow">Fetal phenotypes in otopalatodigital spectrum disorders.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Naudion S, Moutton S, Coupry I, Sole G, Deforges J, Guerineau E, Hubert C, Deves S, Pilliod J, Rooryck C, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Clin Genet. 2016 Mar; 89(3):371-7. Epub 2015 Oct 29.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301451" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Mucopolysaccharidosis Type II<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Scarpa M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301298" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dystrophinopathies<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Darras BT, Urion DK, Ghosh PS. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24278995" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">CASK</i>-Related Disorders<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moog U, Uyanik G, Kutsche K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24006547" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Ornithine Transcarbamylase Deficiency<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lichter-Konecki U, Caldovic L, Morizono H, Simpson K. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301567" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301567" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e0414a6dde0891169d43b90">X-Linked Otopalatodigital Spectrum Disorders - GeneReviews®</a><div class="ralinkpop offscreen_noflow">X-Linked Otopalatodigital Spectrum Disorders - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:02:14-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal103&amp;ncbi_phid=CE8A1166E0404FB10000000006A2024B&amp;ncbi_session=CE8A1166E0414A51_1698SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1393%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1393&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1393/&amp;ncbi_pagename=X-Linked Otopalatodigital Spectrum Disorders - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8A1166E0414A51_1698SID /projects/books/PBooks@5.22 portal103 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>